ArticleCancer reports (Hoboken, N.J.)2024

Diagnostic Challenges due to a Germline Missense MSH2 Variant in a Patient With Immunotherapy-Responsive Locally Advanced Rectal Adenocarcinoma.

Gertruda Evaristo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.